Cytomegalovirus infection accelerates experimental obliterative bronchiolitis via platelet-derived growth factor upregulation.
Koskinen
P
P
Transplantation Laboratory, University of Helsinki, Finland.
Kallio
E
E
Tikkanen
J
J
Bruggeman
C
C
Häyry
P
P
Lemström
K
K
D000818:Animals; D001989:Bronchiolitis Obliterans / Q000503:physiopathology*; D016572:Cyclosporine / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000503:physiopathology*; D005786:Gene Expression Regulation; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010982:Platelet-Derived Growth Factor / Q000096:biosynthesis*; D011183:Postoperative Complications; D051381:Rats; D011919:Rats, Inbred Strains; D011920:Rats, Inbred WF; D017479:Receptors, Platelet-Derived Growth Factor / Q000096:biosynthesis*; D014132:Trachea / Q000637:transplantation*; D014184:Transplantation, Homologous / Q000276:immunology / Q000473:pathology*; D014185:Transplantation, Isogeneic / Q000276:immunology / Q000473:pathology*
D007166:Immunosuppressive Agents; D010982:Platelet-Derived Growth Factor; D016572:Cyclosporine; D017479:Receptors, Platelet-Derived Growth Factor